会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • High yield S-nitrosylation process
    • US07488794B2
    • 2009-02-10
    • US10881713
    • 2004-06-30
    • Robert A. HerrmannDavid Knapp
    • Robert A. HerrmannDavid Knapp
    • C07K1/113C08B37/16
    • C07C381/00C08B37/00C08B37/0012
    • A method for producing a S-nitrosylated species is provided. The method comprises: (a) providing a deoxygenated, alkaline aqueous solution comprising a thiol and a nitrite-bearing species; (b) acidifying the solution by adding acid to the solution while concurrently mixing the solution (e.g., by vigorously stirring the solution) to produce the S-nitrosylated species; and (c) isolating the S-nitrosylated species. The nitrite-bearing species can be, for example, an inorganic nitrite, such as an alkali metal nitrite, or an organic nitrite, such as an alkyl nitrite (e.g., ethyl nitrite, amyl nitrite, isobutyl nitrite or t-butyl nitrite). The thiol is preferably a thiol-containing polysaccharide, a thiol-containing lipoprotein, a thiol-containing amino acid or a thiol-containing protein, and more preferably a thiol-containing polysaccharide such as thiolated cyclodextrin. In many preferred embodiments, the S-nitrosylated species is insoluble in the acidified solution, precipitating upon formation. The S-nitrosylated species can be isolated, for example, by a process in which the precipitate is removed from the solution (e.g., by centrifugation) and the aqueous solvent remaining in the precipitate is sublimated (e.g., by freezing the precipitate and subjecting it to a vacuum). The isolated S-nitrosylated product is preferably protected from heat, light, moisture and oxygen.
    • 2. 发明授权
    • Differential delivery of nitric oxide
    • 差异递送一氧化氮
    • US06706274B2
    • 2004-03-16
    • US09765131
    • 2001-01-18
    • Robert A. HerrmannDavid Knapp
    • Robert A. HerrmannDavid Knapp
    • A61F200
    • A61K9/0024A61K31/21A61K31/53A61K45/06A61L27/54A61L29/16A61L31/16A61L2300/114A61L2300/45A61L2300/602
    • This invention relates to devices and methods for the local, differential delivery of nitric oxide within the body. The devices include devices having at least two differing nitric oxide donor compounds, such as nitric oxide donor compounds having differing half-lives and nitric oxide donor compounds having different release mechanisms. The devices also include devices having at least two chemically distinct compositions to which nitric oxide donor compounds are adsorbed or attached or within which the donor compounds are disposed. The devices are typically used to increase local nitric oxide concentration in the body upon placement of the medical article at a delivery position on or within a patient. The methods of the present invention include a method of treating an atherosclerotic lesion which comprises: exposing the lesion to a first higher concentration of nitric oxide effective to reduce the number of cells within the lesion; and subsequently exposing the lesion to a second lower concentration of nitric oxide effective to inhibit restenosis. The methods of the present invention also include methods for preferentially providing differing nitric oxide donor compounds within different tissues to effect therapy.
    • 本发明涉及用于局部,差异地递送体内一氧化氮的装置和方法。 所述装置包括具有至少两种不同一氧化氮供体化合物的装置,例如具有不同半衰期的一氧化二氮供体化合物和具有不同释放机制的一氧化氮供体化合物。 所述装置还包括具有至少两种化学上不同的组合物的装置,其中一氧化氮供体化合物被吸附或附着,其中配置施主化合物。 该装置通常用于在将医疗用品放置在患者身上或患者内的输送位置时增加身体中的局部一氧化氮浓度。 本发明的方法包括治疗动脉粥样硬化病变的方法,其包括:将病变暴露于第一高浓度的一氧化氮,有效减少损伤内的细胞数; 并随后将病变暴露于有效抑制再狭窄的第二较低浓度的一氧化氮。 本发明的方法还包括优先在不同组织内提供不同的一氧化氮供体化合物以实现治疗的方法。
    • 3. 发明授权
    • High yield S-nitrosylation process
    • 高产率的S-亚硝基化工艺
    • US06417347B1
    • 2002-07-09
    • US09645171
    • 2000-08-24
    • Robert A. HerrmannDavid Knapp
    • Robert A. HerrmannDavid Knapp
    • C08B3702
    • C07C381/00C08B37/00C08B37/0012
    • A method for producing a S-nitrosylated species is provided. The method comprises: (a) providing a deoxygenated, alkaline aqueous solution comprising a thiol and a nitrite-bearing species; (b) acidifying the solution by adding acid to the solution while concurrently mixing the solution (e.g., by vigorously stirring the solution) to produce the S-nitrosylated species; and (c) isolating the S-nitrosylated species. The nitrite-bearing species can be, for example, an inorganic nitrite, such as an alkali metal nitrite, or an organic nitrite, such as an alkyl nitrite (e.g., ethyl nitrite, amyl nitrite, isobutyl nitrite or t-butyl nitrite). The thiol is preferably a thiol-containing polysaccharide, a thiol-containing lipoprotein, a thiol-containing amino acid or a thiol-containing protein, and more preferably a thiol-containing polysaccharide such as thiolated cyclodextrin. In many preferred embodiments, the S-nitrosylated species is insoluble in the acidified solution, precipitating upon formation. The S-nitrosylated species can be isolated, for example, by a process in which the precipitate is removed from the solution (e.g., by centrifugation) and the aqueous solvent remaining in the precipitate is sublimated (e.g., by freezing the precipitate and subjecting it to a vacuum). The isolated S-nitrosylated product is preferably protected from heat, light, moisture and oxygen.
    • 提供了生产S-亚硝基化物质的方法。 该方法包括:(a)提供包含硫醇和含亚硝酸盐的物质的脱氧碱性水溶液; (b)通过向溶液中加入酸来酸化溶液,同时混合溶液(例如通过剧烈搅拌该溶液)以产生S-亚硝基化物质; 和(c)分离S-亚硝基化物质。 含有亚硝酸盐的物质可以是例如无机亚硝酸盐,例如碱金属亚硝酸盐或有机亚硝酸盐,例如亚硝酸烷基酯(例如亚硝酸亚乙酯,亚硝酸戊酯,亚硝酸异丁酯或亚硝酸叔丁酯)。 硫醇优选为含硫醇的多糖,含硫醇的脂蛋白,含巯基的氨基酸或含硫醇的蛋白质,更优选含硫醇的多糖如硫醇化环糊精。 在许多优选实施方案中,S-亚硝基化物质不溶于酸化溶液,在形成时沉淀。 S-亚硝基化物质可以例如通过其中从溶液中除去沉淀物(例如通过离心)并且残留在沉淀物中的水性溶剂升华的方法分离(例如,通过冷冻沉淀物并使其沉淀 到真空)。 分离的S-亚硝基化产物优选保护免受热,光,水分和氧气的影响。
    • 4. 发明授权
    • Differential delivery of nitric oxide
    • 差异递送一氧化氮
    • US07799335B2
    • 2010-09-21
    • US10798592
    • 2004-03-11
    • Robert A. HerrmannDavid Knapp
    • Robert A. HerrmannDavid Knapp
    • A61F2/00A61F13/00
    • A61K9/0024A61K31/21A61K31/53A61K45/06A61L27/54A61L29/16A61L31/16A61L2300/114A61L2300/45A61L2300/602
    • This invention relates to devices and methods for the local, differential delivery of nitric oxide within the body. The devices include devices having at least two differing nitric oxide donor compounds, such as nitric oxide donor compounds having differing half-lives and nitric oxide donor compounds having different release mechanisms. The devices also include devices having at least two chemically distinct compositions to which nitric oxide donor compounds are adsorbed or attached or within which the donor compounds are disposed. The devices are typically used to increase local nitric oxide concentration in the body upon placement of the medical article at a delivery position on or within a patient. The methods of the present invention include a method of treating an atherosclerotic lesion which comprises: exposing the lesion to a first higher concentration of nitric oxide effective to reduce the number of cells within the lesion; and subsequently exposing the lesion to a second lower concentration of nitric oxide effective to inhibit restenosis. The methods of the present invention also include methods for preferentially providing differing nitric oxide donor compounds within different tissues to effect therapy.
    • 本发明涉及用于局部,差异地递送体内一氧化氮的装置和方法。 所述装置包括具有至少两种不同一氧化氮供体化合物的装置,例如具有不同半衰期的一氧化二氮供体化合物和具有不同释放机制的一氧化氮供体化合物。 所述装置还包括具有至少两种化学上不同的组合物的装置,其中一氧化氮供体化合物被吸附或附着,其中配置施主化合物。 该装置通常用于在将医疗用品放置在患者身上或患者内的输送位置时增加身体中的局部一氧化氮浓度。 本发明的方法包括治疗动脉粥样硬化病变的方法,其包括:将病变暴露于第一高浓度的一氧化氮,有效减少损伤内的细胞数; 并随后将病变暴露于有效抑制再狭窄的第二较低浓度的一氧化氮。 本发明的方法还包括优先在不同组织内提供不同的一氧化氮供体化合物以实现治疗的方法。
    • 5. 发明授权
    • High yield S-nitrosylation process
    • 高产率的S-亚硝基化工艺
    • US06762282B2
    • 2004-07-13
    • US10436965
    • 2003-05-13
    • Robert A. HerrmannDavid Knapp
    • Robert A. HerrmannDavid Knapp
    • C07K1113
    • C07C381/00C08B37/00C08B37/0012
    • A method for producing a S-nitrosylated species is provided. The method comprises: (a) providing a deoxygenated, alkaline aqueous solution comprising a thiol and a nitrite-bearing species; (b) acidifying the solution by adding acid to the solution while concurrently mixing the solution (e.g., by vigorously stirring the solution) to produce the S-nitrosylated species; and (c) isolating the S-nitrosylated species. The nitrite-bearing species can be, for example, an inorganic nitrite, such as an alkali metal nitrite, or an organic nitrite, such as an alkyl nitrite (e.g., ethyl nitrite, amyl nitrite, isobutyl nitrite or t-butyl nitrite). The thiol is preferably a thiol-containing polysaccharide, a thiol-containing lipoprotein, a thiol-containing amino acid or a thiol-containing protein, and more preferably a thiol-containing polysaccharide such as thiolated cyclodextrin. In many preferred embodiments, the S-nitrosylated species is insoluble in the acidified solution, precipitating upon formation. The S-nitrosylated species can be isolated, for example, by a process in which the precipitate is removed from the solution (e.g., by centrifugation) and the aqueous solvent remaining in the precipitate is sublimated (e.g., by freezing the precipitate and subjecting it to a vacuum). The isolated S-nitrosylated product is preferably protected from heat, light, moisture and oxygen.
    • 提供了生产S-亚硝基化物质的方法。 该方法包括:(a)提供包含硫醇和含亚硝酸盐的物质的脱氧碱性水溶液; (b)通过向溶液中加入酸来酸化溶液,同时混合溶液(例如通过剧烈搅拌该溶液)以产生S-亚硝基化物质; 和(c)分离S-亚硝基化物质。 含有亚硝酸盐的物质可以是例如无机亚硝酸盐,例如碱金属亚硝酸盐或有机亚硝酸盐,例如亚硝酸烷基酯(例如亚硝酸亚乙酯,亚硝酸戊酯,亚硝酸异丁酯或亚硝酸叔丁酯)。 硫醇优选为含硫醇的多糖,含硫醇的脂蛋白,含巯基的氨基酸或含硫醇的蛋白质,更优选含硫醇的多糖如硫醇化环糊精。 在许多优选实施方案中,S-亚硝基化物质不溶于酸化溶液,在形成时沉淀。 S-亚硝基化物质可以例如通过其中从溶液中除去沉淀物(例如通过离心)并且残留在沉淀物中的水性溶剂升华的方法分离(例如,通过冷冻沉淀物并使其沉淀 到真空)。 分离的S-亚硝基化产物优选保护免受热,光,水分和氧气的影响。
    • 10. 发明授权
    • Lipid-based nitric oxide donors
    • 基于脂质的一氧化氮供体
    • US07696247B2
    • 2010-04-13
    • US10885055
    • 2004-07-06
    • Robert A. HerrmannWendy Naimark
    • Robert A. HerrmannWendy Naimark
    • A61K31/20A01N33/26C07C205/00C07C207/00C07C241/00C07C243/00
    • A61L29/16A61K45/06A61L15/44A61L31/16A61L2300/114A61L2300/416C07C243/42C07J41/0055Y10T436/104165
    • Novel nitric-oxide releasing lipid molecules are provided which comprise a lipid molecule selected from (a) phosphoglycerides, (b) lipids having a sphingosine base as a backbone, (c) monoacylglyerols, (d) diacylglycerols, (e) glycosylacylglycerols, and (f) sterol compounds of the formula: where R is a branched aliphatic chain of eight or more carbon atoms, wherein the lipid molecule is provided with a nitric-oxide containing group which comprises (a) a —S—N═O moiety, (b) a —O—N═O moiety, or (c) a a moiety. Also provided are methods of forming such nitric oxide releasing lipid molecules. Various pharmaceutical compositions, topical liquids and drug delivery systems comprising the nitric-oxide releasing lipid molecules are also described. Further provided are methods for therapeutically administering nitric oxide to patients, methods of treating or preventing various conditions, methods for promoting wound healing and methods of reducing the cells present in an atherosclerotic lesion, which methods utilize the nitric-oxide releasing lipid molecules.
    • 提供新的一氧化氮释放脂质分子,其包含选自(a)磷酸甘油酯,(b)具有鞘氨醇碱作为主链的脂质的脂质分子,(c)单酰基甘醇,(d)二酰基甘油,(e)糖基酰基甘油和( f)下式的甾醇化合物:其中R是具有8个或更多个碳原子的支链脂族链,其中所述脂质分子具有含一氧化氮的基团,其包含(a)-S-N = O部分,( b)-O-N = O部分,或(c)aa部分。 还提供了形成这种一氧化氮释放脂质分子的方法。 还描述了包含释放一氧化氮的脂质分子的各种药物组合物,局部液体和药物递送系统。 还提供了向患者治疗性给予一氧化氮的方法,治疗或预防各种病症的方法,促进伤口愈合的方法以及减少存在于动脉粥样硬化病变中的细胞的方法,该方法利用释放一氧化氮的脂质分子。